Table 1.
miRNA | Target gene | Study model | Function/activity |
---|---|---|---|
miR-23a~27a~24-220 | SATB2, Runx2 | Primary rat osteoblasts, mouse pre-osteoblast cell line MC3T3-E1 |
Suppress osteogenic differentiation |
A panel of 11 miRNAs (miR-23a, -30c, -34c, -133a, -135a, -137, -204, -205, -217, -218, -338)21 | Runx2 | MC3T3-E1, mouse chondroprogenitor cell line ATDC5 |
Suppress osteogenic differentiation; promote early chondrogenic differentiation and suppress chondrocyte maturation |
miR-204/21122, 37 | Runx2 | Multiple mesenchymal cell lines, human MSCs, primary mouse bone marrow stromal cells; primary mouse vascular smooth muscle cells (VSMCs), aortic calcification mouse model |
Suppress osteogenic differentiation, promote adipogenic differentiation; downregulated in calcified VSMCs, suppress VSMCs/artery calcification |
miR-32023 | Runx2 | Human MSCs | Suppress osteogenic differentiation, promote adipogenic differentiation |
miR-2861~396024 | HDAC5, Hoxa2 | Primary mouse osteoblasts, mouse mesenchymal cell line ST2 |
Promote osteogenic differentiation |
miR-2225 | HDAC6 | Human adipose tissue–derived MSCs | Promote osteogenic differentiation, suppress adipogenic differentiation |
miR-449a26 | HDAC1 | Human-induced pluripotent stem cells (iPSCs) | Promote osteogenic differentiation |
miR-455-3p27 | Runx2 | ATDC5 | Promote early chondrogenic differentiation and suppress chondrocyte maturation |
miR-128 | HDAC4 | Primary chicken chondrocytes | Promote chondrocyte maturation |
miR-338-3p29 | Runx2, Fgfr2 | Ovariectomy-induced osteoporosis mice | Upregulated in osteoporosis mice |
miR-29a30 | HDAC4 | Transgenic mice overexpressing miR-29a | Mitigate glucocorticoid-induced osteoporosis |
miR-34c31 | Runx2 | Human osteosarcoma cell line SAOS-2 and U2OS, human osteosarcoma biopsies | Downregulated in osteosarcoma |
miR-23a32 | Runx2, CXCL12 | Multiple osteosarcoma cell lines, osteosarcoma nude mice model |
Downregulated in osteosarcoma cell lines, suppress osteosarcoma tumor growth in nude mice |
miR-30a33 | Runx2 | Multiple osteosarcoma cell lines | Downregulated in osteosarcoma cell lines |
miR-20335, 36 | Runx2 | Multiple prostate/breast cancer cell lines, bone metastasis mice model |
Downregulated in prostate/breast cancer cell lines, suppress prostate/breast cancer metastasis in vivo |
miR-13536 | Runx2 | Multiple breast cancer cell lines, bone metastasis mice model |
Downregulated in breast cancer cell lines, suppress breast cancer metastasis in vivo |
miR-30b/c38 | Runx2 | Human coronary artery smooth muscle cells (CASMCs) | Downregulated in calcified CASMCs and human coronary artery atherosclerosis |
miR-133a39 | Runx2 | Primary mouse VSMCs | Downregulated in calcified VSMCs |
miR-20540 | Runx2 | Human aortic smooth muscle cells (HASMCs) | Downregulated in calcified HASMCs |
miR-10553 | Runx2 | Primary human osteoarthritic chondrocytes/biopsies | Downregulated in osteoarthritis |
miR-14554 | Sox9 | Primary human healthy chondrocytes | Overexpressing miR-145 promotes Runx2 expression |
miR-36555, 56 | HDAC4 | Primary human osteoarthritic chondrocytes/biopsies | Upregulated in osteoarthritis |